Bayesian Parameter Estimation for Characterizing the Cyclic Variation of Echocardiographic Backscatter to Assess the Hearts of Asymptomatic Type 2 Diabetes Mellitus Subjects

Ultrasound in Medicine and Biology

Volumn 37, Issue 5, 2011, Pages 805-812

  Anderson, Christian C ^a   Gibson, Allyson A ^a   Schaffer, Jean E ^a   Peterson, Linda R ^a   Holland, Mark R ^a   Miller, James G ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Bayesian probability theory; Cardiomyopathy; Diabetes mellitus; Echocardiography; Tissue characterization; Ultrasonics

Indexed keywords

BAYESIAN PARAMETER ESTIMATION; BAYESIAN PROBABILITY THEORY; CARDIOMYOPATHY; CYCLIC VARIATIONS; DIABETES MELLITUS; ECHOCARDIOGRAPHIC IMAGES; LEFT VENTRICLES; MYOCARDIAL PROPERTIES; NONINVASIVE TECHNIQUE; NORMAL CONTROLS; PARAMETERS CHARACTERIZING; PIECE-WISE LINEAR FUNCTIONS; REGION OF INTEREST; RISETIMES; SLEW RATE; TISSUE CHARACTERIZATION; TYPE 2 DIABETES MELLITUS; TYPE-2 DIABETES; ULTRASONIC BACKSCATTER; WAVE FORMS;

BACKSCATTERING; DELAY CONTROL SYSTEMS; ECHOCARDIOGRAPHY; PIECEWISE LINEAR TECHNIQUES; TISSUE; ULTRASONIC TESTING; ULTRASONICS;

PARAMETER ESTIMATION;

HEMOGLOBIN A1C;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BAYES THEOREM; CONTROLLED STUDY; DIABETES CONTROL; ECHOCARDIOGRAPHY; FEMALE; HEART CYCLE; HEART FAILURE; HEART LEFT VENTRICLE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIGHT SCATTERING; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WAVEFORM;

ADULT; ANIMALS; BAYES THEOREM; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; RISK FACTORS;

EID: 79954628173     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.02.001     Document Type: Article

References (40)

1. Augustus A.S., Kako Y., Yagyu H., Goldberg I.J. Routes of FA delivery to cardiac muscle: Modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 2003, 284:E331-E339.
2. Barzilai B., Madaras E.I., Sobel B.E., Miller J.G., Pérez J.E. Effects of myocardial contraction on ultrasonic backscatter before and after ischemia. Am J Physiol 1984, 247:H478-H483.
3. Bello V.D., Giampietro O., Matteucci E., Giorgi D., Bertini A., Piazza F., Talini E., Paterni M., Giusti C. Ultrasonic tissue characterization analysis in type 1 diabetes: A very early index of diabetic cardiomyopathy?. G Ital Cardiol 1998, 28:1128-1137.
4. Bello V.D., Talarico L., Picano E., Muro C.D., Landini L., Paterni M., Matteucci E., Giusti C., Giampietro O. Increased echodensity of myocardial wall in the diabetic heart: An ultrasound tissue characterization study. J Am Coll Cardiol 1995, 25:1408-1415.
5. Borradaile N.M., Schaffer J.E. Lipotoxicity in the heart. Curr Hypertens Rep 2005, 7:412-417.
6. Bretthorst G.L., Hutton W.C., Garbow J.R., Ackerman J.J. Exponential parameter estimation (in NMR) using Bayesian probability theory. Concepts Magn Reson 2005, 27A:55-63.
7. Carley A.N., Severson D.L. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005, 1734:112-126.
8. Chiu H.C., Kovacs A., Ford D.A., Hsu F.F., Garcia R., Herrero P., Saffitz J.E., Schaffer J.E. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001, 107:813-822.
9. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocrinol Rev 2004, 25:543-567.
10. Finch-Johnston A.E., Gussak H.M., Mobley J., Holland M.R., Petrovic O., Pérez J.E., Miller J.G. Cyclic variation of integrated backscatter: Dependence of time delay on the echocardiographic view used and the myocardial segment analyzed. J Am Soc Echocardiogr 2000, 13:9-17.
11. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., Kelly D.P. A critical role for pparalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc Natl Acad Sci U S A 2003, 100:1226-1231.
12. Gibson A.A., Schaffer J.E., Peterson L.R., Bilhorn K.R., Robert K.M., Haider T.A., Farmer M.S., Holland M.R., Miller J.G. Quantitative analysis of the magnitude and time delay of cyclic variation of myocardial backscatter from asymptomatic type 2 diabetes mellitus subjects. Ultrasound Med Biol 2009, 35:1458-1467.
13. Gong H.P., Tan H.W., Fang N.N., Song T., Li S.H., Zhong M., Zhang W., Zhang Y. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract 2009, 83:300-307.
14. Hamby R.I., Zoneraich S., Sherman L. Diabetic cardiomyopathy. JAMA 1974, 229:1749-1754.
15. Holland M.R., Gibson A., Kirschner C., Hicks D., Ludomirsky A., Singh G. Intrinsic myoarchitectural differences between the left and right ventricles of fetal human hearts: An ultrasonic backscatter feasibility study. J Am Soc Echocardiogr 2009, 22:170-176.
16. Holland M.R., Gibson A.A., Peterson L.R., Areces M., Schaffer J.E., Perez J.E., Miller J.G. Measurements of the cyclic variation of myocardial backscatter from two-dimensional echocardiographic images as an approach for characterizing diabetic cardiomyopathy. J Cardiometab Syndr 2007, 1:149-152.
17. Holland M.R., Wallace K.D., Miller J.G. Potential relationships among myocardial stiffness, the measured level of myocardial backscatter (" image brightness" ), and the magnitude of the systematic variation of backscatter (cyclic variation) over the heart cycle. J Am Soc Echocardiogr 2004, 17:1131-1137.
18. Hu X., Wang J., Sun Y., Jiang X., Sun B., Fu H., Guo R. Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in patients with chronic coronary artery disease. Clin Cardiol 2003, 26:485-488.
19. Jaynes E.T., Bretthorst G.L. Probability theory: the logic of science 2003, Cambridge University Press, Oxford, UK.
20. Jeffreys H. Theory of probability 1961, Oxford University Press, Oxford, UK.
21. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 1974, 34:29-34.
22. Kusminski C., Shetty S., Orci L., Unger R., Scherer P. Diabetes and apoptosis: Lipotoxicity. Apoptosis 2009, 14:1484-1495.
23. Madaras E.I., Barzilai B., Perez J.E., Sobel B.E., Miller J.G. Changes in myocardial backscatter throughout the cardiac cycle. Ultrason Imaging 1983, 5:229-239.
24. Mobley J., Banta C., Gussak H., Perez J.E., Miller J.G. Clinical tissue characterization: Online determination of magnitude and time delay of myocardial backscatter. Video Journal of Echocardiography 1995, 5:40-48.
25. Mottley J.G., Glueck R.M., Perez J.E., Sobel B.E., Miller J.G. Regional differences in the cyclic variation of myocardial backscatter that parallel regional differences in contractile performance. J Acoust Soc Am 1984, 76:1617-1623.
26. Naito J., Masuyama T., Mano T., Yamamoto K., Doi Y., Kondo H., Nagano R., Inoue M., Hori M. Influence of preload, afterload, and contractility on myocardial ultrasonic tissue characterization with integrated backscatter. Ultrasound Med Biol 1996, 22:305-312.
27. Ng A.C., Delgado V., Bertini M., van der Meer R.W., Rijzewijk L.J., Shanks M., Nucifora G., Smit J.W., Diamant M., Romijn J.A., de Roos A., Leung D.Y., Lamb H.J., Bax J.J. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 2009, 104:1398-1401.
28. Nielsen L.B., Bartels E.D., Bollano E. Overexpression of apolipoprotein b in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002, 277:27014-27020.
29. Pérez J.E., McGill J.B., Santiago J.V., Schechtman K.B., Waggoner A.D., Miller J.G., Sobel B.E. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992, 19:1154-1162.
30. Peterson L.R., Herrero P., Schechtman K.B., Racette S.B., Waggoner A.D., Kisrieva-Ware Z., Dence C., Klein S., Marsala J., Meyer T., Gropler R.J. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004, 109:2191-2196.
31. Poirier P., Bogaty P., Garneau C., Marois L., Dumesnil J.G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001, 24:5-10.
32. Rijzewijk L.J., van der Meer R.W., Smit J.W., Diamant M., Bax J.J., Hammer S., Romijn J.A., de Roos A., Lamb H.J. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008, 52:1793-1799.
33. Schannwell C.M., Schneppenheim M., Perings S., Plehn G., Strauer B.E. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002, 98:33-39.
34. Sivia D.S., Skilling J. Data analysis: A Bayesian tutorial 2006, Oxford Univ Press, Oxford, UK.
35. Skilling J. Nested sampling for general Bayesian computation. Bayesian Analysis 2006, 1:833-860.
36. Stremmel W. Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J Clin Invest 1988, 81:844-852.
37. Wagner R.F., Wear K.A., Perez J.E., McGill J.B., Schechtman K.B., Miller J.G. Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of Bayesian classifiers. J Am Coll Cardiol 1995, 25:1706-1711.
38. Wickline S.A., Thomas L.J., Miller J.G., Sobel B.E., Pérez J.E. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 1985, 72:183-192.
39. Witteles R.M., Fowler M.B. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 2008, 51:93-102.
40. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., Unger R.H. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci U S A 2000, 97:1784-1789.